Avalyn's upsized IPO; Alector ends another study in GSK partnership
Avalyn's upsized IPO; Alector ends another study in GSK partnership
Avalyn's upsized IPO; Alector ends another study in GSK partnership
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.